Age at diagnosis | Casesa | Controlsa | ORhet | 95% CI |
P
1
| ORhom | 95% CI |
P
1
|
P
het
|
---|
≤ 50 years | 11,794 | 34,988 | 0.99 | 0.93, 1.05 | 0.69 | 0.68 | 0.53, 0.86 | 0.003 | |
> 50 years | 23,264 | 34,988 | 0.97 | 0.93, 1.02 | 0.24 | 0.84 | 0.70, 1.00 | 0.04 | |
NK | 554 | | | | | | | | |
Total | 35,612 | 34,988 | 0.98 | 0.94, 1.02 | 0.23 | 0.79 | 0.67, 0.92 | 0.003 | 0.89 |
- aFive studies (ABCFS, MARIE, MEC, MTLGEBCS and SASBAC) that selected all cases on the basis of age at diagnosis (Table S3 in Additional file 1) were excluded from this stratified analysis; two small studies (CTS and NBCS) that had no heterozygote or rare homozygote cases in one of the age stratum were also excluded. H0, null hypothesis; NK, not known; ORhet, odds ratio comparing rs10235235 AG genotype versus AA genotype; ORhom, odds ratio comparing rs10235235 GG genotype versus AA genotype; P1, test of H0 no association between rs10235235 and breast cancer risk; Phet, test of H0 no difference between stratum specific estimates.